Survival Rate

"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.

Descriptor ID	D015996
MeSH Number(s)	E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
Concept/Terms	Survival Rate Survival Rate Rate, Survival Rates, Survival Survival Rates Mean Survival Time Mean Survival Time Mean Survival Times Survival Time, Mean Survival Times, Mean Time, Mean Survival Times, Mean Survival Cumulative Survival Rate Cumulative Survival Rate Cumulative Survival Rates Rate, Cumulative Survival Rates, Cumulative Survival Survival Rate, Cumulative Survival Rates, Cumulative

Below are MeSH descriptors whose meaning is more general than "Survival Rate".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Data Collection [E05.318.308]
Vital Statistics [E05.318.308.985]
Mortality [E05.318.308.985.550]
Survival Rate [E05.318.308.985.550.900]
Health Care [N]
Population Characteristics [N01]
Demography [N01.224]
Vital Statistics [N01.224.935]
Mortality [N01.224.935.698]
Survival Rate [N01.224.935.698.826]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Measurements [N06.850.505]
Demography [N06.850.505.400]
Vital Statistics [N06.850.505.400.975]
Mortality [N06.850.505.400.975.550]
Survival Rate [N06.850.505.400.975.550.900]
Epidemiologic Methods [N06.850.520]
Data Collection [N06.850.520.308]
Vital Statistics [N06.850.520.308.985]
Mortality [N06.850.520.308.985.550]
Survival Rate [N06.850.520.308.985.550.900]

Below are MeSH descriptors whose meaning is related to "Survival Rate".

Below are MeSH descriptors whose meaning is more specific than "Survival Rate".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.

Bar chart showing 262 publications over 26 distinct years, with a maximum of 20 publications in 2018 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1998	0	3	3
2001	0	6	6
2002	0	7	7
2003	0	10	10
2004	0	1	1
2005	0	5	5
2006	0	9	9
2007	0	5	5
2008	0	14	14
2009	0	9	9
2010	0	11	11
2011	0	14	14
2012	0	19	19
2013	0	17	17
2014	0	18	18
2015	0	16	16
2016	2	12	14
2017	1	14	15
2018	0	20	20
2019	0	8	8
2020	1	19	20
2021	0	15	15
2022	0	1	1
2023	0	1	1
2024	0	3	3

Below are the most recent publications written about "Survival Rate" by people in Profiles.

Yang Z, Bai YZ, Yan Y, Hachem RR, Witt CA, Vazquez Guillamet R, Byers DE, Marklin GF, Kreisel D, Nava RG, Meyers BF, Kozower BD, Patterson GA, Hartwig MG, Heiden BT, Puri V. Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score. Am J Transplant. 2024 Jul; 24(7):1279-1288.

View in: PubMed
Abe JV, Park SY, Haiman CA, Cheng I, Le Marchand L, Hernandez BY, Wilkens LR. Thyroid Cancer Survival in the Multiethnic Cohort Study. Int J Environ Res Public Health. 2024 Mar 10; 21(3).

View in: PubMed
Cirulli GO, Corsi N, Rakic I, Stephens A, Chiarelli G, Finati M, Davis M, Tinsley S, Sood A, Buffi N, Lughezzani G, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis. BJU Int. 2024 May; 133(5):555-563.

View in: PubMed
Sood A, Grauer R, Diaz-Insua M, Tewari AK, Hemal AK, Shrivastava A, Peabody JO, Jeong W, Abdollah F, Rudzinski JK, Andrews JR, Gorin MA, Bhandari M, Menon M. 15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer. Prostate Cancer Prostatic Dis. 2023 Dec; 26(4):778-786.

View in: PubMed
Corsi NJ, Messing EM, Sood A, Keeley J, Bronkema C, Rakic N, Jamil M, Dalela D, Arora S, Piontkowski AJ, Majdalany SE, Butaney M, Rakic I, Li P, Menon M, Rogers CG, Abdollah F. Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis. Clin Genitourin Cancer. 2022 12; 20(6):e498-e505.

View in: PubMed
Byron SA, Hendricks WPD, Nagulapally AB, Kraveka JM, Ferguson WS, Brown VI, Eslin DE, Mitchell D, Cornelius A, Roberts W, Isakoff MS, Oesterheld JE, Wada RK, Rawwas J, Neville K, Zage PE, Harrod VL, Bergendahl G, VanSickle E, Dykema K, Bond J, Chou HC, Wei JS, Wen X, Reardon HV, Roos A, Nasser S, Izatt T, Enriquez D, Hegde AM, Cisneros F, Christofferson A, Turner B, Szelinger S, Keats JJ, Halperin RF, Khan J, Saulnier Sholler GL, Trent JM. Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion. Cancer Res. 2021 12 01; 81(23):5818-5832.

View in: PubMed
Blakely ML, Tyson JE, Lally KP, Hintz SR, Eggleston B, Stevenson DK, Besner GE, Das A, Ohls RK, Truog WE, Nelin LD, Poindexter BB, Pedroza C, Walsh MC, Stoll BJ, Geller R, Kennedy KA, Dimmitt RA, Carlo WA, Cotten CM, Laptook AR, Van Meurs KP, Calkins KL, Sokol GM, Sanchez PJ, Wyckoff MH, Patel RM, Frantz ID, Shankaran S, D'Angio CT, Yoder BA, Bell EF, Watterberg KL, Martin CA, Harmon CM, Rice H, Kurkchubasche AG, Sylvester K, Dunn JCY, Markel TA, Diesen DL, Bhatia AM, Flake A, Chwals WJ, Brown R, Bass KD, St Peter SD, Shanti CM, Pegoli W, Skarda D, Shilyansky J, Lemon DG, Mosquera RA, Peralta-Carcelen M, Goldstein RF, Vohr BR, Purdy IB, Hines AC, Maitre NL, Heyne RJ, DeMauro SB, McGowan EC, Yolton K, Kilbride HW, Natarajan G, Yost K, Winter S, Colaizy TT, Laughon MM, Lakshminrusimha S, Higgins RD. Initial Laparotomy Versus Peritoneal Drainage in Extremely Low Birthweight Infants With Surgical Necrotizing Enterocolitis or Isolated Intestinal Perforation: A Multicenter Randomized Clinical Trial. Ann Surg. 2021 10 01; 274(4):e370-e380.

View in: PubMed
AlHilli MM, Rybicki L, Carr C, Yao M, Amarnath S, Vargas R, Debernardo R, Michener C, Rose PG. Development and validation of a comprehensive clinical risk-scoring model for prediction of overall survival in patients with endometrioid endometrial carcinoma. Gynecol Oncol. 2021 12; 163(3):511-516.

View in: PubMed
Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, Fuchs HE, Martinez Tyson D, Tortolero-Luna G, Fedewa SA, Jemal AM, Siegel RL. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J Clin. 2021 11; 71(6):466-487.

View in: PubMed
Heyliger SO, Soliman KFA, Saulsbury MD, Reams RR. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma. Biomolecules. 2021 08 12; 11(8).

View in: PubMed

People

Explore

Similar Concepts

Top Journals